Key regions: Japan, India, Italy, Brazil, South Korea
The Anti-Hypertensive Drugs market in CIS has been experiencing steady growth in recent years.
Customer preferences: Patients in CIS countries have been increasingly seeking medical treatment for hypertension, leading to a rise in demand for anti-hypertensive drugs. Additionally, there has been a shift towards preventive healthcare, with more people taking medication to prevent the onset of hypertension.
Trends in the market: The market for anti-hypertensive drugs in CIS is dominated by generic drugs, which are more affordable for patients. However, there has been an increase in demand for branded drugs due to their perceived higher quality and efficacy. Pharmaceutical companies have been investing in research and development to create new and improved drugs to meet this demand.
Local special circumstances: One of the main challenges in the CIS market is the lack of access to healthcare in certain regions. This has led to a rise in self-medication, with patients purchasing drugs without a prescription. Additionally, there is a lack of awareness about hypertension and its risks, leading to low diagnosis rates and poor management of the condition.
Underlying macroeconomic factors: The CIS region has been experiencing economic growth in recent years, leading to an increase in disposable income and healthcare spending. This has contributed to the growth of the anti-hypertensive drugs market. However, political instability in some countries and the ongoing COVID-19 pandemic have had a negative impact on the market. Supply chain disruptions and reduced access to healthcare have led to a decrease in sales for some companies.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
